David A Cory Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David A Cory.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David A Cory. David A Cory is President and CEO in Eiger BioPharmaceuticals, Inc. ($EIGR).
Latest Insider Trading Transactions of David A Cory
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Option Exercise | A | 9.99 | 281,000 | 2,807,190 | 281,000 | |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Grant | A | 0.00 | 47,000 | 0 | 117,846 | 70.8 K to 117.8 K (+66.34 %) |
| Mar 13 2020 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Option Exercise | A | 5.60 | 230,000 | 1,288,000 | 230,000 | |
| Mar 13 2020 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Grant | A | 7.31 | 1,500 | 10,965 | 69,346 | 67.8 K to 69.3 K (+2.21 %) |
| Sep 06 2019 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Grant | A | 7.95 | 1,500 | 11,921 | 67,846 | 66.3 K to 67.8 K (+2.26 %) |
| Apr 26 2019 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Buy | P | 11.26 | 343 | 3,862 | 66,346 | 66 K to 66.3 K (+0.52 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Option Exercise | A | 14.31 | 200,000 | 2,862,000 | 200,000 | |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Grant | A | 7.95 | 1,500 | 11,921 | 66,003 | 64.5 K to 66 K (+2.33 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Grant | A | 7.95 | 1,500 | 11,921 | 64,503 | 63 K to 64.5 K (+2.38 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Grant | A | 8.03 | 1,500 | 12,049 | 63,003 | 61.5 K to 63 K (+2.44 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Grant | A | 9.90 | 1,500 | 14,854 | 61,503 | 60 K to 61.5 K (+2.50 %) |
| Mar 26 2019 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Grant | A | 8.20 | 1,325 | 10,868 | 60,003 | 58.7 K to 60 K (+2.26 %) |
| Feb 06 2019 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Buy | P | 14.13 | 227 | 3,208 | 58,678 | 58.5 K to 58.7 K (+0.39 %) |
| Mar 16 2018 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Option Exercise | A | 9.50 | 190,000 | 1,805,000 | 190,000 | |
| Mar 14 2017 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Option Exercise | A | 11.75 | 133,000 | 1,562,750 | 133,000 | |
| Aug 19 2016 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Buy | P | 15.70 | 1,562 | 24,523 | 58,451 | 56.9 K to 58.5 K (+2.75 %) |
| Mar 28 2016 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Option Exercise | A | 15.89 | 285,991 | 4,544,397 | 285,991 |
Page: 1